Adjuvants for vaccines

Details Adjuvants for vaccines Adjuvants for vaccines

1988-03-24

1991-09-10

Nucker, Christine

Drug, bio-affecting and body treating compositions

Lymphokine

424 78, 424 81, 424 83, 424 93, A61K 3700, A61K 3174

Patent

active

050472380

ABSTRACT:
An efficacious parenterally administered inactivated canine coronavirus vaccine which provides systemic, humoral protection and also protection of the intestinal tract in dogs from infection by virulent canine coronavirus is produced. A method for propagation of the canine coronavirus and its attenuation and a method of evaluating the effectiveness of a canine coronavirus vaccine in canines is also disclosed.

REFERENCES:
patent: 3651213 (1972-03-01), Wallis et al.
Monsanto Technical Bulletin No. IC/FP-7, pp. 1-16. EMA.
Polyvinyl Chemical Industries Technical Bulletin, "Neocryl A640 for Water Resistant Industrial Coatings or Inks", 8/5/80.

Affiliated with

Also associated with

Rating

Adjuvants for vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adjuvants for vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adjuvants for vaccines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-538828